{
  "meta": {
    "title": "Renal_Tumors",
    "url": "https://brainandscalpel.vercel.app/renal-tumors-6b23ee7e.html",
    "scrapedAt": "2025-11-29T18:32:25.640Z"
  },
  "questions": [
    {
      "id": 13636,
      "choices": [
        {
          "id": 54505,
          "text": "<p><span style=\"font-size:16px;\">Reduced rate of proliferation</span></p>"
        },
        {
          "id": 54506,
          "text": "<p><span style=\"font-size:16px;\">Absence of metastasis</span></p>"
        },
        {
          "id": 54507,
          "text": "<p><span style=\"font-size:16px;\">Anaplasia</span></p>"
        },
        {
          "id": 54508,
          "text": "<p><span style=\"font-size:16px;\">Sparing of basement membrane</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:16px;\">A 4-year-old boy is evaluated by his pediatrician for 1 week of intermittent hematuria. On examination he appears well developed and well nourished, except a right flank mass is palpable. A biopsy of the mass is performed, which reveals primitive looking small blue cells with glomerular and tubular structures (image). Which of the following indicates poor prognosis for the patient?</span></p><p>&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:16px;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/02/08/screenshot-2024-02-08-194503.jpg\" alt=\"\" width=\"300\" height=\"202\"></span></p>",
      "unique_key": "Q7050545",
      "question_audio": null,
      "question_video": null,
      "map_id": 32292,
      "difficulty_level": "intermediate",
      "subjects_id": [
        5
      ],
      "solution": "<p><span style=\"font-size:16px;\"><strong>Ans. C. Anaplasia</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option C:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Clinical features and history points towards</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\">The most common renal malignancy in children is Wilms tumor, usually presented with a palpable mass or hematuria. This tumor, most often caused by a mutation of the WT1 tumor suppressor gene (chromosome 11p13) and is characterized histologically by as a triphasic tumor. The presence of anaplasia is important factor indicating aggressive nature of the tumor.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong><u>Explanation:</u></strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option A:</strong> <strong>Reduced rate of proliferation</strong> actually suggests a better prognosis as it indicates slower tumor growth.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option B:</strong> <strong>Absence of metastasis</strong> is a favorable prognostic factor, not a poor prognostic indicator.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option D:</strong> <strong>Sparing of basement membrane&nbsp;</strong>suggests the tumor is less invasive, which is associated with better outcomes.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong><u>Educational Objective:</u></strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Wilms tumor (nephroblastoma):</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:12.0pt;\">Most common malignant renal tumor of childhood (usually before age 5).</span></li><li><span style=\"font-size:12.0pt;\">Classic presentation: asymptomatic abdominal/flank mass; sometimes hematuria, hypertension, or abdominal pain.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Histology: so-called triphasic pattern:</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:12.0pt;\">Blastemal component → small round blue cells</span></li><li><span style=\"font-size:12.0pt;\">Epithelial component → primitive tubules and glomeruloid structures</span></li><li><span style=\"font-size:12.0pt;\">Stromal component → fibrous tissue, muscle, cartilage</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">What determines prognosis in Wilms tumor?</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:12.0pt;\">Most patients with Wilms tumor do very well today (survival &gt;90%) thanks to surgery and chemotherapy.</span></li><li><span style=\"font-size:12.0pt;\">But there are certain factors that predict worse prognosis:</span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:12.0pt;\">Anaplasia (unfavorable histology) → the single most important adverse prognostic feature.</span></li></ul></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Characterized by:</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:12.0pt;\">Markedly enlarged, pleomorphic (very variable in size and shape) hyperchromatic nuclei</span></li><li><span style=\"font-size:12.0pt;\">Atypical mitotic figures</span></li><li><span style=\"font-size:12.0pt;\">Indicates genetic instability → leads to chemotherapy resistance.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Other factors:</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:12.0pt;\">Older age (&gt;10 years)</span></li><li><span style=\"font-size:12.0pt;\">Large tumor size</span></li><li><span style=\"font-size:12.0pt;\">Tumor rupture before/during surgery</span></li><li><span style=\"font-size:12.0pt;\">Bilateral disease</span></li><li><span style=\"font-size:12.0pt;\">Metastases at diagnosis</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Ref: Robbins and Cotran pathologic basis of disease 10th edition page: 292</strong></span></p>",
      "correct_choice_id": 54507,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "ImageBased",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 14995,
      "choices": [
        {
          "id": 59940,
          "text": "<p style=\"text-align:justify\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Minimal change disease </span></span></p>"
        },
        {
          "id": 59941,
          "text": "<p style=\"text-align:justify\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">IgA nephropathy </span></span></p>"
        },
        {
          "id": 59942,
          "text": "<p style=\"text-align:justify\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Membranous glomerulopathy </span></span></p>"
        },
        {
          "id": 59943,
          "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Focal segmental glomerulosclerosis</span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which of the following is the commonest nephropathy seen in a patient with cancer? </span></span></span></p>",
      "unique_key": "Q7923389",
      "question_audio": null,
      "question_video": null,
      "map_id": 32296,
      "difficulty_level": "beginner",
      "subjects_id": [
        5
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. C) Membranous glomerulopathy </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C: </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Membranous Glomerulopathy</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: This is the correct answer as it is the most <strong>common type of nephropathy </strong>associated with <strong>cancer, particularly solid tumors</strong>. It&#39;s characterized by<strong> diffuse thickening of the glomerular basement membrane </strong>due to<strong> subepithelial immune complex deposits</strong>. Patients often present with nephrotic syndrome.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A: Minimal Change Disease</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Minimal change disease typically presents with<strong> nephrotic syndrome </strong>and is most commonly seen in<strong> children</strong>. It&#39;s characterized by the <strong>loss of foot processes of podocytes visible </strong>under an <strong>electron microscope </strong>but with <strong>normal-appearing glomeruli </strong>under a <strong>light microscope</strong>. It&#39;s <strong>less </strong>commonly associated with<strong> malignancies</strong> compared to <strong>membranous glomerulopathy</strong>, although it has been linked with<strong> Hodgkin disease.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B: IgA Nephropathy</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Also known as <strong>Berger&#39;s disease</strong>, IgA nephropathy is marked by <strong>IgA immune complexes </strong>deposited in the <strong>glomerular mesangium</strong>. It&#39;s<strong> not </strong>typically associated with <strong>malignancy </strong>and presents with <strong>hematuria, </strong>and sometimes with <strong>proteinuria.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D: Focal Segmental Glomerulosclerosis</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: FSGS is characterized by<strong> scarring in segmented regions of the glomeruli. </strong>It can occur as a <strong>primary renal disease </strong>or <strong>secondary to other conditions</strong>, including some<strong> cancers</strong>, but is <strong>not </strong>the most common <strong>cancer-related nephropathy</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong> </span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Membranous glomerulopathy </strong>is most commonly linked to<strong> malignancies </strong>and presents as <strong>nephrotic syndrome </strong>characterized by <strong>proteinuria, hypoalbuminemia, and edema</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><em>&nbsp;</em></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><em><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">(Ref: Robbins 10<sup>th</sup>/ 912) </span></em></strong></span></span></p>",
      "correct_choice_id": 59942,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 15004,
      "choices": [
        {
          "id": 59976,
          "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Hemihypertrophy</span></span></p>"
        },
        {
          "id": 59977,
          "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Aniridia </span></span></p>"
        },
        {
          "id": 59978,
          "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Hypertension </span></span></p>"
        },
        {
          "id": 59979,
          "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Bilateral polycystic kidney </span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Wilm&rsquo;s tumor is associated with all of the following except</span></span></span></p>",
      "unique_key": "Q8582599",
      "question_audio": null,
      "question_video": null,
      "map_id": 32297,
      "difficulty_level": "intermediate",
      "subjects_id": [
        5
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. D) Bilateral polycystic kidney </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D: </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Bilateral polycystic kidney:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Bilateral polycystic kidney is <strong>not </strong>typically associated with <strong>Wilm&#39;s tumor. Polycystic kidney disease (PKD) </strong>is a separate<strong> genetic disorder </strong>characterized by the development of<strong> fluid-filled cysts </strong>in the kidneys.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A: Hemihypertrophy:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> <strong>Wilm&#39;s tumor </strong>is associated with <strong>Beckwith Wiedmann syndrome </strong>which has <strong>hemihypertrophy </strong>as one of the components. Hemihypertrophy is the <strong>asymmetric growth </strong>of one side or part of the body. </span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B: Aniridia:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Aniridia refers to the <strong>absence of the iris. Wilm&#39;s tumor </strong>is associated with<strong> WAGR syndrome (Wilm&#39;s tumor, Aniridia, Genitourinary anomalies, and mental Retardation).</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C: Hypertension:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> <strong>Wilm&#39;s tumor </strong>can cause<strong> hypertension due to the secretion of renin </strong>by the tumor cells. This can lead to <strong>renovascular hypertension.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational objective:</span></u></strong><u> </u></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Wilm&#39;s tumor</strong>, also known as <strong>nephroblastoma, </strong>is <strong>not </strong>associated with <strong>bilateral polycystic kidney.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong><strong><em><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">(Ref: Robbins 10<sup>th</sup> 481)</span></span></em></strong></strong></span></span></p>",
      "correct_choice_id": 59979,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 15006,
      "choices": [
        {
          "id": 59984,
          "text": "<p><span style=\"font-size:12.0pt;\">Mutant VHL gene</span></p>"
        },
        {
          "id": 59985,
          "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Loss of 3p</span></p>"
        },
        {
          "id": 59986,
          "text": "<p><span style=\"font-size:12.0pt;\">Trisomy 7/17</span></p>"
        },
        {
          "id": 59987,
          "text": "<p><span style=\"font-size:12.0pt;\">Loss of 3q</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">The cytogenetics of chromophilic renal cell carcinoma is characterized by:</span></p>",
      "unique_key": "Q1566718",
      "question_audio": null,
      "question_video": null,
      "map_id": 32298,
      "difficulty_level": "difficult",
      "subjects_id": [
        5
      ],
      "solution": "<p style=\"text-align:justify;\"><span style=\"font-size:16px;\"><strong>Ans. C) Trisomy 7/17</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:16px;\"><strong>Option C:</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p><span style=\"font-size:16px;\">Chromophilic renal cell carcinoma is a distinct type of RCC.<strong> Trisomy 7/17:</strong> Trisomy 7/17 is a characteristic <strong>cytogenetic aberration </strong>found in<strong> chromophilic renal cell carcinoma</strong>. It is one of the defining features of this subtype.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:16px;\"><strong><u>Explanation:</u></strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:16px;\"><strong>Option A: Mutant VHL gene: </strong>The <strong>VHL gene </strong>is commonly associated with <strong>clear cell renal cell carcinoma (RCC), not chromophilic RCC.</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:16px;\"><strong>Option B: Loss of 3p:</strong> <strong>Loss of 3p </strong>is a genetic alteration commonly observed in <strong>clear cell RCC, not chromophilic RCC</strong>.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:16px;\"><strong>Option D: Loss of 3q:</strong> Loss of 3q is also associated with<strong> clear cell RCC, not chromophilic RCC.</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:16px;\"><strong><u>Educational objective:</u></strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:16px;\"><strong>Chromophilic renal cell carcinoma </strong>is characterized by <strong>specific cytogenetic aberrations</strong>, notably loss of the Y chromosome, trisomy / tetrasomy &nbsp;of<strong> chromosomes 7 and 17,</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"color:black;font-size:16px;\"><strong>(Ref: Robbins 10<sup>th</sup>/ 950)</strong></span></p>",
      "correct_choice_id": 59986,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "InvestigationBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 15007,
      "choices": [
        {
          "id": 59988,
          "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Nephrogenic rests </span></span></p>"
        },
        {
          "id": 59989,
          "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Monophasic morphology </span></span></p>"
        },
        {
          "id": 59990,
          "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Anaplasia</span></span></p>"
        },
        {
          "id": 59991,
          "text": "<p style=\"text-align:justify\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Capsular infiltration </span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">In Wilm&rsquo;s tumor, the following finding leads to emergence of resistance to chemotherapy:</span></span></span></p>",
      "unique_key": "Q2166661",
      "question_audio": null,
      "question_video": null,
      "map_id": 32299,
      "difficulty_level": "intermediate",
      "subjects_id": [
        5
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. C) Anaplasia </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C: </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Anaplasia:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Anaplasia is a<strong> histological </strong>feature characterized by the <strong>presence of cells with large, hyperchromatic, pleomorphic nuclei and abnormal mitoses. </strong>It correlates with underlying<strong> p53 </strong>mutations and is associated with the emergence of<strong> resistance to chemotherapy.</strong></span></span></span></p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>5% </strong>of tumors reveal <strong>anaplasia</strong>, defined as the presence of cells with<strong> large, hyperchromatic, pleomorphic nuclei and abnormal mitoses </strong>and the presence of <strong>anaplasia correlates </strong>with underlying <strong><em>p53 </em>mutations </strong>and the emer&shy;gence of <strong>resistance to chemotherapy. </strong></span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A: Nephrogenic rests:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Nephrogenic rests are <strong>precursor lesions </strong>seen in <strong>Wilms tumor</strong>. They are<strong> not </strong>directly associated with <strong>resistance to chemotherapy</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B: Monophasic morphology:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Monophasic morphology refers to the<strong> histological appearance </strong>of the <strong>tumor</strong>, where it predominantly consists of one type of tissue. While it may <strong>influence tumor behavior, </strong>it is not specifically linked to resistance to chemotherapy.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D: Capsular infiltration:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Capsular infiltration refers to the<strong> invasion of the tumor </strong>beyond its<strong> encapsulated boundary</strong>. While it may indicate a<strong> more aggressive tumor behavior, </strong>it is<strong> not </strong>directly linked to<strong> resistance to chemotherapy.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational objective: </span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Anaplasia in Wilms tumor</strong>, characterized by specific <strong>cellular </strong>features and associated <strong>p53 mutations</strong>, leads to the emergence of <strong>resistance to chemotherapy</strong>, <strong>highlighting </strong>the importance of <strong>recognizing </strong>this histological feature for <strong>prognosis and treatment planning</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\"><strong><em><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">(Ref: Robbins 10<sup>th</sup>/ 481) </span></span></em></strong> </span></span></span></p>",
      "correct_choice_id": 59990,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 15016,
      "choices": [
        {
          "id": 60024,
          "text": "<p><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Schistosomiasis </span></span></p>"
        },
        {
          "id": 60025,
          "text": "<p><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ascariasis</span></span></p>"
        },
        {
          "id": 60026,
          "text": "<p><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Malaria</span></span></p>"
        },
        {
          "id": 60027,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Any of the above </span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Transitional cell carcinoma bladder is associated with which of the following?</span></span></span></p>",
      "unique_key": "Q3722182",
      "question_audio": null,
      "question_video": null,
      "map_id": 32293,
      "difficulty_level": "beginner",
      "subjects_id": [
        5
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. A) Schistosomiasis </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A: </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Schistosomiasis:&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Schistosomiasis, </strong>particularly infection with <strong>Schistosoma haematobium, </strong>is well-established as a <strong>risk factor </strong>for the development of <strong>bladder cancer</strong>, especially in<strong> endemic areas </strong>such as<strong> Egypt and Sudan</strong>. The <strong>eggs </strong>of the parasite are <strong>laid in the bladder wall</strong>, causing <strong>chronic inflammation </strong>which can lead to<strong> mucosal squamous metaplasia, dysplasia, and potentially neoplasia</strong>, often resulting in<strong> squamous cell carcinoma</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B (Ascariasis):</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Ascariasis is an infection caused by <strong>Ascaris lumbricoides</strong>, an <strong>intestinal roundworm</strong>. It is <strong>not </strong>typically associated with the development of<strong> bladder cancer</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C (Malaria):</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Malaria is caused by<strong> Plasmodium parasites. </strong>It affects <strong>red blood cells and the liver</strong>, but it is<strong> not </strong>associated with the development of <strong>bladder cancer</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective: </span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Schistosoma haematobium infection </strong>is a significant <strong>risk factor </strong>for <strong>bladder cancer </strong>in <strong>endemic areas</strong>, leading to <strong>chronic inflammation </strong>and an<strong> increased risk of squamous metaplasia, dysplasia, and carcinoma</strong>. </span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><em><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">(Ref: Robbins 10<sup>th</sup>/ 960)</span></em></strong></span></span></p>",
      "correct_choice_id": 60024,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 15017,
      "choices": [
        {
          "id": 60028,
          "text": "<p style=\"text-align:justify\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">p53 </span></span></p>"
        },
        {
          "id": 60029,
          "text": "<p style=\"text-align:justify\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">p16 </span></span></p>"
        },
        {
          "id": 60030,
          "text": "<p style=\"text-align:justify\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">p7 </span></span></p>"
        },
        {
          "id": 60031,
          "text": "<p style=\"text-align:justify\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">KRAS </span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Gene associated with superficial papillary urothelial neoplasm?</span></span></span></p>",
      "unique_key": "Q2095891",
      "question_audio": null,
      "question_video": null,
      "map_id": 32294,
      "difficulty_level": "difficult",
      "subjects_id": [
        5
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B) p16 </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">(p16):&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The p16 gene, also known as<strong> CDKN2A</strong>, encodes for the <strong>cyclin-dependent kinase inhibitor p16/INK4a</strong>, which is a <strong>tumor suppressor</strong> that regulates the <strong>cell cycle</strong>. <strong>Deletions</strong> affecting the <strong>9p21 region </strong>where <strong>CDKN2A </strong>is located are common in <strong>superficial noninvasive papillary tumors </strong>of the bladder, making<strong> p16 a gene </strong>associated with these<strong> tumors</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Particularly common </strong>(occurring in <strong>30% to 60% </strong>of tumors) are losses of genetic material on <strong>chromosome 9 </strong>(including monosomy or <strong>deletions of 9p and 9q</strong>). These abnormalities are often the only chromosomal changes present in <strong>superficial noninvasive papillary tumors. </strong>The <strong>9p deletions </strong>(9p20) affects tumor<strong> suppressor gene CDKN2A, </strong>which encodes the <strong>cyclin-dependent kinase </strong>inhibitor <strong>p16/INK4a and ARF</strong>, a protein that augments<strong> p53 function</strong>. </span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A (p53):&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The <strong>p53 gene </strong>is a well-known<strong> tumor suppressor gene </strong>that is often<strong> mutated </strong>in a variety of cancers, leading to <strong>loss of cell cycle control </strong>and <strong>enabling the formation of tumors</strong>. While<strong> p53 </strong>mutations are common in many cancers, they are <strong>not </strong>the most commonly associated <strong>gene </strong>with<strong> superficial papillary urothelial neoplasms.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C (p7):&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">There is <strong>no </strong>well-characterized <strong>tumor suppressor gene </strong>known as <strong>p7 </strong>in the context of <strong>superficial papillary urothelial neoplasms</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D (KRAS):</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> The<strong> KRAS gene </strong>is an <strong>oncogene </strong>that can lead to<strong> cancer </strong>when<strong> mutated, </strong>as it encodes a <strong>protein </strong>that is involved in <strong>cell signaling pathways </strong>that control<strong> cell growth</strong>. While <strong>KRAS mutations </strong>can be present in <strong>many cancers</strong>, they are<strong> not </strong>the most commonly associated <strong>mutation </strong>with<strong> superficial papillary urothelial neoplasms</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective: </span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Losses of genetic material </strong>on<strong> chromosome 9</strong>, including deletions of<strong> 9p21 </strong>that affect the<strong> CDKN2A gene </strong>encoding <strong>p16/INK4a, </strong>are often the only <strong>chromosomal changes </strong>present in </span><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">superficial papillary urothelial neoplasm</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong> </strong>. </span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><strong><em><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">(Ref: Robbins 10<sup>th</sup>/ 958)</span></span></em></strong><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"color:black\"> </span></span></span></span></p>",
      "correct_choice_id": 60029,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 15018,
      "choices": [
        {
          "id": 60032,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Pleomorphic </span></span></span></p>"
        },
        {
          "id": 60033,
          "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Embryonal </span></span></p>"
        },
        {
          "id": 60034,
          "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Alveolar </span></span></p>"
        },
        {
          "id": 60035,
          "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Botryoid</span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Most common type of rhabdomyosarcoma is?</span></span></span></p>",
      "unique_key": "Q7874661",
      "question_audio": null,
      "question_video": null,
      "map_id": 32295,
      "difficulty_level": "intermediate",
      "subjects_id": [
        5
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B) Embryonal </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B (Embryonal):&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Embryonal rhabdomyosarcoma </strong>is the most common type of<strong> rhabdomyosarcoma</strong>, particularly in <strong>infancy and childhood</strong>. This <strong>subtype </strong>often presents as a <strong>grapelike mass</strong>, especially when occurring in<strong> hollow organs like </strong>the <strong>vagina or urinary bladder</strong>, referred to as<strong> sarcoma botryoides</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A (Pleomorphic):</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> <strong>Pleomorphic rhabdomyosarcoma </strong>is a <strong>type of rhabdomyosarcoma </strong>that typically occurs in <strong>adults </strong>and is characterized by a <strong>wide variety of cell shapes and sizes</strong>. It is not the most common type of rhabdomyosarcoma.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C (Alveolar):&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Alveolar rhabdomyosarcoma </strong>is<strong> less common </strong>than the <strong>embryonal subtype </strong>and has a <strong>distinctive histological appearance resembling pulmonary alveoli</strong>. It typically occurs in older children and teenagers.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D (Botryoid):&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Botryoid rhabdomyosarcoma </strong>is a variant of the <strong>embryonal type </strong>that manifests as a <strong>polypoid, grapelike mass. </strong>While it is a <strong>recognized subtype</strong>, it is<strong> not </strong>the most common form of <strong>rhabdomyosarcoma overall</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">MC&nbsp;</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">sarcoma in <strong>infancy </strong>or childhood is <strong><em>embryonal rhabdomyosarcoma</em></strong>. In some cases, it manifests as a polypoid grapelike mass (sarcoma botryoides). </span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">MC&nbsp;</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">sarcoma in the bladder in <strong>adults </strong>is <strong>leiomyosarcoma.</strong></span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\"><strong><strong><em><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">(Ref: Robbins 10<sup>th</sup>/ 962)</span></span></em></strong></strong></span></span></span></p>",
      "correct_choice_id": 60033,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 15009,
      "choices": [
        {
          "id": 59996,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Common in adult </span></span></span></p>"
        },
        {
          "id": 59997,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Associated with deletion of chromosome 11p13 </span></span></span></p>"
        },
        {
          "id": 59998,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Associated with MIC-2 genes </span></span></span></p>"
        },
        {
          "id": 59999,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Commonest presentation is hematuria</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">True statement regarding Wilms tumour is:</span></span></span></p>",
      "unique_key": "Q4966232",
      "question_audio": null,
      "question_video": null,
      "map_id": 32288,
      "difficulty_level": "intermediate",
      "subjects_id": [
        5
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B) Associated with deletion of chromosome 11p13 </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Associated with deletion of chromosome 11p13:&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Mutations in the <strong>WT1 gene</strong>, located on <strong>chromosome 11p13, </strong>are commonly associated with <strong>Wilms tumor</strong>. Therefore, option B is <strong>correct</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation: </span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A: Common in adult:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>&nbsp;Wilms tumor (nephroblastoma) </strong>primarily occurs in <strong>children</strong>, typically between the <strong>ages of 2 and 5 years old</strong>. It is <strong>very rare in adults</strong>, so <strong>option A is incorrect.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C: Associated with MIC-2 genes:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> MIC-2 gene is <strong>not specifically </strong>associated with <strong>Wilms tumor</strong>; instead, it is related to<strong> Ewing sarcoma</strong>. Therefore,<strong> option C is incorrect</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D: Commonest presentation is hematuria:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> The<strong> most common </strong>presentation of Wilms tumor is an <strong>abdominal mass</strong>, <strong>not hematuria</strong>. Therefore,<strong> option D is incorrect.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational objective:</span></u></strong> </span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Wilms tumor </strong>is primarily a <strong>childhood kidney tumor</strong>, commonly associated with<strong> mutations in the WT1 gene located on chromosome 11p13</strong>, highlighting the genetic basis of this malignancy and aiding in its<strong> diagnosis and management.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><strong><em><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\"><strong><em><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">(Ref: Robbins 10<sup>th</sup>/ 481) </span></span></em></strong> </span></span></span></em></strong></p>",
      "correct_choice_id": 59997,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 15010,
      "choices": [
        {
          "id": 60000,
          "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Invades renal vein </span></span></p>"
        },
        {
          "id": 60001,
          "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Hematuria may occur </span></span></p>"
        },
        {
          "id": 60002,
          "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Arises from proximal convoluted tubule </span></span></p>"
        },
        {
          "id": 60003,
          "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">More common in females </span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">All are true about renal cell cancer except: </span></span></span></p>",
      "unique_key": "Q6118789",
      "question_audio": null,
      "question_video": null,
      "map_id": 32289,
      "difficulty_level": "beginner",
      "subjects_id": [
        5
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. D) More common in females&nbsp; </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D:</span></strong> </span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Renal cell carcinoma </strong>has a higher incidence in <strong>males compared to females</strong>. The <strong>male-to-female ratio </strong>is approximately<strong> 2:1</strong>. This <strong>gender predilection </strong>is observed across<strong> various age groups.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong> Renal cell carcinoma (RCC) </strong>is known for its<strong> propensity to invade nearby structures</strong>. The <strong>renal vein </strong>is commonly involved, and extension into the <strong>renal vein </strong>is not uncommon in advanced cases. This<strong> invasion </strong>can potentially <strong>lead to the spread of cancer cells </strong>to <strong>other parts of the body</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> <strong>Hematuria </strong>is a common symptom of <strong>renal cell carcinoma. </strong>As the <strong>tumor grows</strong>, it can invade<strong> blood vessels </strong>within the <strong>kidney</strong>, leading to<strong> bleeding </strong>which is then <strong>excreted </strong>in the<strong> urine</strong>. However, it&#39;s important to note that <strong>not all cases of RCC present </strong>with <strong>hematuria, </strong>and other symptoms such as<strong> flank pain or a palpable mass may </strong>also be<strong> observed.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> <strong>RCC </strong>typically arises from the<strong> proximal convoluted tubule </strong>of the nephron. The exact cell type involved is a<strong> clear cell carcinoma</strong>, which accounts for the <strong>majority of RCC cases</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational objective :</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Renal cell carcinoma </strong>has a <strong>higher </strong>incidence in <strong>males </strong>compared to females</span></span> </span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><em><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">(Ref: Robbins 10<sup>th</sup>/ 950) </span></em></strong></span></span></p>",
      "correct_choice_id": 60003,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 15011,
      "choices": [
        {
          "id": 60004,
          "text": "<p><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Lung carcinoma </span></span></p>"
        },
        {
          "id": 60005,
          "text": "<p><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Renal cell carcinoma </span></span></p>"
        },
        {
          "id": 60006,
          "text": "<p><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Endometrial carcinoma </span></span></p>"
        },
        {
          "id": 60007,
          "text": "<p><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Hepatocellular carcinoma </span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">VHL syndrome is associated most commonly with which carcinoma:</span></span></span></p>",
      "unique_key": "Q3046716",
      "question_audio": null,
      "question_video": null,
      "map_id": 32290,
      "difficulty_level": "beginner",
      "subjects_id": [
        5
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B) Renal cell carcinoma </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The <strong>primary tumors </strong>associated with<strong> VHL syndrome </strong>are <strong>renal cell carcinoma (RCC), hemangioblastomas </strong>of the <strong>central nervous system, and pheochromocytomas</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A: Lung carcinoma:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> <strong>VHL </strong>syndrome is<strong> not </strong>classically associated with<strong> lung carcinoma. </strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C: Endometrial carcinoma</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: <strong>VHL syndrome </strong>is<strong> not </strong>known for an <strong>increased risk of endometrial carcinoma. </strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D: Hepatocellular carcinoma:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> <strong>VHL </strong>syndrome is <strong>not </strong>typically associated with <strong>hepatocellular carcinoma</strong>. </span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational objective: </span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>VHL syndrome </strong>increases the risk of certain tumors, particularly <strong>renal cell carcinoma</strong>, <strong>hemangioblastomas, and pheochromocytomas. </strong>A secondary objective is to discern the types of carcinomas not typically associated with VHL syndrome. </span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><strong><em><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\"><strong><em><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">(Ref: Robbins 10<sup>th</sup>/ 949) </span></span></em></strong> </span></span></span></em></strong></p>",
      "correct_choice_id": 60005,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 15012,
      "choices": [
        {
          "id": 60008,
          "text": "<p style=\"text-align:justify\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Renal cell cancer </span></span></p>"
        },
        {
          "id": 60009,
          "text": "<p style=\"text-align:justify\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Wilms tumor </span></span></p>"
        },
        {
          "id": 60010,
          "text": "<p><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Carcinoma lung</span></span></p>"
        },
        {
          "id": 60011,
          "text": "<p><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Hepatocellular carcinoma </span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Pseudohermaphroditism is seen with which of the following tumor?</span></span></span></p>",
      "unique_key": "Q1855999",
      "question_audio": null,
      "question_video": null,
      "map_id": 32291,
      "difficulty_level": "intermediate",
      "subjects_id": [
        5
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B) Wilms tumor</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">(Wilms tumor):</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Wilms tumor, or <strong>nephroblastoma, </strong>is a<strong> childhood kidney cancer</strong>. <strong>Denys-Drash syndrome </strong>is a <strong>rare disorder </strong>associated with <strong>Wilms tumor </strong>and is characterized by<strong> gonadal dysgenesis, </strong>which can present as <strong>male pseudohermaphroditism, </strong>and <strong>nephropathy </strong>often leading to<strong> renal failure</strong>. Abnormalities in the <strong>WT1 </strong>gene are a <strong>hallmark </strong>of this syndrome.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><em><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Denys-Drash syndrome </span></em></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">is characterized by <strong>gonadal dysgenesis (male pseudohermaphroditism) </strong>and early-onset <strong>nephropathy leading to renal failure</strong>. The characteristic <strong>glomerular lesion </strong>in these patients is <strong>diffuse mesangial sclerosis</strong>. These patients also demonstrate <strong>germline abnormalities in <em>WT1. </em></strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">In addition to <strong>Wilms tumors</strong>, these individuals are also at<strong> increased risk </strong>for developing <strong>germ cell tumors </strong>called <strong>gonadoblastomas, </strong>almost certainly a <strong>consequence of disruption </strong>in <strong>normal gonadal development</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A (Renal cell cancer):</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Renal cell cancer is<strong> not </strong>typically associated with <strong>pseudohermaphroditism, </strong>which is a condition where an individual has <strong>reproductive organs or secondary sex characteristics of both sexes</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C (Carcinoma lung):</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Lung carcinoma is a <strong>malignant lung tumor </strong>characterized by <strong>uncontrolled cell growth in tissues of the lung. </strong>This condition is not related to pseudohermaphroditism.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D (Hepatocellular carcinoma): </span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Hepatocellular carcinoma is the <strong>most common </strong>type of<strong> primary liver cancer</strong>. It has <strong>no direct </strong>association with<strong> pseudohermaphroditism.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong> </span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Denys-Drash syndrome, </strong>which is associated with <strong>Wilms tumor</strong>, can present with <strong>male pseudohermaphroditism </strong>due to mutations in the<strong> WT1 gene</strong>, and this can lead to <strong>disorders of sexual development. </strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><strong><em><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">(Ref: Robbins 10<sup>th</sup>/ 481)</span></span></em></strong></p>",
      "correct_choice_id": 60009,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    }
  ]
}